1
|
Kim JK, Tam M, Karp JM, Oh C, Kim G, Solomon E, Concert CM, Vaezi AE, Li Z, Tran T, Zan E, Corby P, Feron-Rigodon M, Del Vecchio Fitz C, Goldberg JD, Hochman T, Givi B, Jacobson A, Persky M, Hu KS. A Phase II Trial Evaluating Rapid Mid-Treatment Nodal Shrinkage to Select for Adaptive Deescalation in p16+ Oropharyngeal Cancer Patients Undergoing Definitive Chemoradiation. Int J Radiat Oncol Biol Phys 2023; 117:S68-S69. [PMID: 37784553 DOI: 10.1016/j.ijrobp.2023.06.374] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) The purpose of this study is to determine if rapid mid-treatment nodal shrinkage (RMNS) can identify patients with p16+ oropharyngeal cancer (OPC) who can be safely deescalated with reduced dose chemoradiation therapy (CRT). The primary endpoint was 2-year progression free survival (PFS). MATERIALS/METHODS Inclusion criteria were as follows: T1-3, N1, M0 (AJCC 8th edition) p16+ OPC with <10 pack-year smoking history. All patients were initially planned for standard dose CRT (70 Gy) and weekly cisplatin. Patients were evaluated with a CT scan at week 4 for RMNS, defined as >40% nodal volumetric reduction from baseline. If RMNS was achieved, they proceeded to deescalated CRT (60 Gy). If not, they received standard CRT. Biomarker correlates were collected at baseline and week 4 of CRT including plasma TTMV (tumor tissue modified viral) HPV DNA and MRI diffusion weighted imaging (DWI). Univariate logistic regression analyses (UVA) were performed to evaluate predictors of RMNS. Odds ratios with 95% CI are reported, using a p<0.05 for statistical significance with a two-sided test. Wilcoxon rank sum tests were used to evaluate differences between the two groups using p < 0.05, 2-sided) for statistical significance. All statistical procedures were performed using R () with no adjustments for multiple testing. RESULTS Thirty-six patients were enrolled: median age: 60 years; 81% male; primary site: 36% base of tongue, 53% tonsil, 11% both; T-stage: 39% T1, 50% T2, 11% T3; N-stage: 100% N1; any smoking history: 58% yes, 42% no; 67% (n = 24) had RMNS and received deescalated CRT while the remaining proceeded to standard CRT. At a median follow-up of 32.4 months, 2-year PFS between the standard and deescalated groups were 91.7% vs 90.9%, respectively (p = 0.97). All patients with recurrence underwent successful salvage treatment with 2-year OS 100% for all patients. On UVA, rapid TTMV HPV DNA clearance (baseline to week 4) (OR 12.0 [1.65-250], p = 0.034), lower MRI diffusivity (ADC) at baseline (OR 0.79 [0.61-0.97], p = 0.042) and week 4 (OR 0.76 [0.60-0.91], p = 0.009), and higher MRI diffusional kurtosis at baseline (OR 1.09 [1.01-1.21], p = 0.051) and week 4 (OR 1.24 [1.09-1.52], p = 0.009) were significantly associated with RMNS. When comparing the deescalated and standard cohorts, the mean baseline and week 4 MRI ADC were significantly lower and week 4 MRI diffusional kurtosis was significantly higher in the deescalated group. CONCLUSION In this phase II study, rapid mid-treatment nodal shrinkage appeared to select favorable risk p16+ oropharynx cancer patients for treatment de-escalation. Rapid clearance of TTMV HPV DNA at week 4 as well as MRI DWI biomarkers of low ADC and high diffusional kurtosis values were correlated with RMNS. A larger study is planned to incorporate RMNS and biomarkers for further treatment de-escalation. Additional trial information is available at ClinicalTrials.gov (Identifier: NCT03215719).
Collapse
Affiliation(s)
- J K Kim
- Department of Radiation Oncology, NYU Langone Health, New York, NY
| | - M Tam
- Department of Radiation Oncology, NYU Langone Health, New York, NY
| | - J M Karp
- NYU Grossman School of Medicine, Department of Radiation Oncology, New York City, NY
| | - C Oh
- Biostatistics, Department of Population Health, NYU Langone Health, New York, NY
| | - G Kim
- NYU Langone Health, New York, NY
| | - E Solomon
- Weill Cornell Medicine, Cornell University, New York, NY
| | - C M Concert
- Department of Radiation Oncology, NYU Langone Health, New York, NY
| | - A E Vaezi
- Perlmutter Cancer Center NYU Langone Long Island, Mineola, NY
| | - Z Li
- Department of Medical Oncology, NYU Langone Health, New York, NY
| | - T Tran
- Department of Otolaryngology, NYU Langone Health, New York, NY
| | - E Zan
- NYU School of Medicine and Langone Medical Center, New York, NY, United States
| | - P Corby
- University of Pennsylvania, School of Dental Medicine, Philadelphia, PA
| | | | | | - J D Goldberg
- New York University School of Medicine, New York, NY
| | - T Hochman
- NYU Langone Medical Center, New York, NY
| | - B Givi
- Memorial Sloan Kettering Cancer Center, New York, NY
| | - A Jacobson
- Department of Otolaryngology-Head and Neck Surgery, NYU Langone Health, New York, NY
| | - M Persky
- Department of Otolaryngology, NYU Langone Health, New York, NY
| | - K S Hu
- NYU Langone Medical Center, New York, NY
| |
Collapse
|
2
|
Kim J, Karp J, Hu K, Vaezi A, Liu C, Rybstein M, Li Z, Jacobson A, Persky M, Givi B, Tam M. Disease Characteristics, Patterns of Care and Survival Outcomes in Patients with Synovial Cell Sarcoma of the Head and Neck (HNSCS). Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
3
|
Kim J, Tam M, Oh C, Feron-Rigodon M, Joseph B, Vaezi A, Li Z, Tran T, Kim G, Zan E, Corby P, Vecchio Fitz CD, Goldberg J, Hochman T, Givi B, Jacobson A, Persky M, Persky M, Hu K. Circulating Tumor HPV-DNA Kinetics in p16+ Oropharyngeal Cancer Patients Undergoing Adaptive Radiation De-Escalation Based on Mid-Treatment Nodal Response. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2022.07.1385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
4
|
Gordon A, Patel A, Zhou F, Jacobson A, Tam M, Givi B. Head and Neck Sweat Gland Carcinomas: Clinical Characteristics and Patterns of Care. Int J Radiat Oncol Biol Phys 2022. [DOI: 10.1016/j.ijrobp.2021.12.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
5
|
Jacobson A, Besirli CG, Bohnsack BL. Outcomes of combined endoscopic vitrectomy and posteriorly placed glaucoma drainage devices in pediatric patients. BMC Ophthalmol 2022; 22:149. [PMID: 35365117 PMCID: PMC8976343 DOI: 10.1186/s12886-022-02373-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Accepted: 03/22/2022] [Indexed: 12/01/2022] Open
Abstract
Background This study aims to describe outcomes of posteriorly-placed glaucoma drainage devices (GDD) with concurrent endoscopic vitrectomy in pediatric patients with glaucoma and corneal opacification. Methods This retrospective case series identified patients under 18 years of age who underwent posteriorly-placed GDD implantation with concurrent endoscopic vitrectomy between 2012 and 2021. Data collected included ocular diagnoses, prior intraocular surgeries, type and position of GDD, surgical complications, and additional surgeries. Preoperative and final visual acuity, intraocular pressure (IOP), number of glaucoma medications, and exam findings were also recorded. Surgical data included type and position of GDD, Success was defined as IOP between 5-21 mmHg without visually devastating complication or need for additional glaucoma surgery. Results Ten patients (14 eyes) with sclerocornea (6), Peters Anomaly (4), corneal decompensation from increased IOP (3), and corneal scar (1) underwent combined endoscopic vitrectomy with posteriorly-placed GDD (Baerveldt (10 eyes), Ahmed (4 eyes)) at 4.6 ± 5.8 years of age. Four eyes of 3 patients remained successful at final follow-up, while 10 eyes of 7 patients required 2.4 ± 1.3 additional surgeries for glaucoma (7) or hypotony (3). Kaplan Meier analysis demonstrated 1- and 2-year survival rates of 36% and 18%, respectively. At final follow-up (3.7 ± 2.4 years), after an average of 4.4 ± 2.4 glaucoma surgeries, 13 of 14 eyes had obtained IOP control on significantly fewer (p<0.0001) IOP-lowering medications. Additional complications included retinal detachment (2), chronic corneal graft failure (2), phthisis (1) and band keratopathy (1). Conclusions Management of glaucoma in pediatric eyes with corneal opacification is challenging and often requires multiple surgeries. A combined endoscopic vitrectomy and posteriorly placed GDD is a viable technique to establish aqueous humor outflow. Although the success rate is low, this surgical approach may be useful in ultimately obtaining IOP control and preserving vision in these complex eyes. Supplementary Information The online version contains supplementary material available at 10.1186/s12886-022-02373-3.
Collapse
Affiliation(s)
- A Jacobson
- Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall Street, Ann Arbor, Michigan, 48105, USA
| | - C G Besirli
- Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, 1000 Wall Street, Ann Arbor, Michigan, 48105, USA
| | - B L Bohnsack
- Department of Ophthalmology, Northwestern University Feinberg School of Medicine, 645 N. Michigan Ave, #440, Chicago, Illinois, 60611, USA. .,Division of Ophthalmology, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Ave, Box 70, Chicago, Illinois, 60611, USA.
| |
Collapse
|
6
|
Byun D, Spuhler K, Daar D, Anzai L, Witek L, Levine J, Jacobson A, Barbee D, Hu K. Dose Perturbation From Titanium Plates in Post-Operative Oral Cavity Volumetric Modulated Arc Therapy: The Utility of Model-Based Algorithm. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.573] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Karp J, Hu K, Belinsky I, Jacobson A, Li Z, Gottlieb M, Persky M, Givi B, Tam M. Incidence, Treatment and Clinical Outcomes for Lacrimal Gland Cancer. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.1148] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
8
|
Lebwohl M, Stein Gold L, Papp K, Han G, Pariser D, Lin T, Harris S, Jacobson A. Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study. J Eur Acad Dermatol Venereol 2021; 35:1152-1160. [DOI: 10.1111/jdv.17113] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Accepted: 12/16/2020] [Indexed: 11/30/2022]
Affiliation(s)
- M.G. Lebwohl
- Icahn School of Medicine at Mount Sinai New York NY USA
| | | | - K. Papp
- Probity Medical Research and K. Papp Clinical Research Waterloo ON Canada
| | - G. Han
- Icahn School of Medicine at Mount Sinai New York NY USA
| | - D.M. Pariser
- Eastern Virginia Medical School and Virginia Clinical Research, Inc. Norfolk VA USA
| | - T. Lin
- Ortho Dermatologics† Bridgewater NJ USA
| | - S. Harris
- Bausch Health US, LLC† Bridgewater NJ USA
| | | |
Collapse
|
9
|
Papp K, Menter A, Leonardi C, Soung J, Weiss S, Pillai R, Jacobson A. Long-term efficacy and safety of brodalumab in psoriasis through 120 weeks and after withdrawal and retreatment: subgroup analysis of a randomized phase III trial (AMAGINE-1). Br J Dermatol 2020; 183:1037-1048. [PMID: 32286683 PMCID: PMC7754427 DOI: 10.1111/bjd.19132] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/07/2020] [Indexed: 12/30/2022]
Abstract
BACKGROUND Brodalumab is efficacious for the treatment of moderate-to-severe plaque psoriasis through 52 weeks. OBJECTIVES To evaluate the efficacy and safety of brodalumab through 120 weeks, including following withdrawal and retreatment. METHODS At baseline, patients were randomized to brodalumab (n = 222) or placebo (n = 220). At week 12, patients achieving a static Physician's Global Assessment (sPGA) score of 0 or 1 (sPGA 0/1) with brodalumab were rerandomized to brodalumab (n = 83) or placebo (n = 84; later re-treated with brodalumab if sPGA ≥ 3 occurred), and patients receiving placebo switched to brodalumab (n = 208). Safety was assessed by exposure-adjusted rates of treatment-emergent adverse events. RESULTS Among those who achieved sPGA 0/1 at week 12 and were rerandomized to brodalumab, 96% and 80% using observed data, respectively, and 74% and 61% using nonresponder imputation, respectively, achieved 75% improvement in Psoriasis Area and Severity Index (PASI 75) and PASI 100 at week 120. Following withdrawal from brodalumab, return of disease occurred after a mean ± SD duration of 74·7 ± 50·5 days. Among those who switched from brodalumab to placebo at week 12, PASI 75 rates using observed data and nonresponder imputation were 55% and 51% at week 20, respectively and 94% and 75% at week 120, respectively; PASI 100 rates at week 120 were 75% and 60%, respectively. Efficacy was maintained through week 120 in those receiving brodalumab after placebo. No new safety signals were observed. CONCLUSIONS These findings indicate that brodalumab is efficacious and safe for continuous long-term treatment of psoriasis, and support the potential for response after discontinuation and retreatment.
Collapse
Affiliation(s)
- K Papp
- Probity Medical Research and K Papp Clinical Research, Waterloo, ON, Canada
| | - A Menter
- Baylor Scott & White, Dallas, TX, USA
| | | | - J Soung
- Southern California Dermatology, Santa Ana, CA, USA
| | - S Weiss
- Direct Dermatology, Palo Alto, CA, USA
| | - R Pillai
- Bausch Health US, LLC, Petaluma, CA, USA
| | - A Jacobson
- Ortho Dermatologics (a division of Bausch Health US, LLC), Bridgewater, NJ, USA
| |
Collapse
|
10
|
Trivers R, Jacobson A, Manning JT. Radiographic digit ratios (2D:4D) of Afro-Caribbean children: Comparisons with published data from white children. Early Hum Dev 2020; 146:105072. [PMID: 32485482 DOI: 10.1016/j.earlhumdev.2020.105072] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/16/2020] [Revised: 05/11/2020] [Accepted: 05/12/2020] [Indexed: 01/06/2023]
Abstract
BACKGROUND Digit ratio (2D:4D) from soft-tissue measurements of fingers from children and adults from Black and White ethnic groups show sex differences (males<females) and group differences (Black< White). However, less is known about such differences in radiographic 2D:4D. AIM To consider sex and ethnic differences in radiographic 2D:4D of children of Afro-Caribbean descent and to compare these means with "standards" from White children. SUBJECTS AND METHODS A cross-sectional design with samples from Afro-Caribbean children aged 6 to 11 years compared to published radiographic measurements for White children in the Fels Longitudinal Study. RESULTS Radiographic 2D:4D showed ethnic differences such that Afro-Caribbeans<Whites. There was an age-stable right-side sex difference (boys<girls) in the 2D:4D of the distal phalanx and the distal soft-tissue tip in the Afro-Caribbean children but not in the proximal- and middle-phalanges or the composite length of the phalanges. Sex differences in 2D:4D (boys<girls) were present in the White children in the middle and proximal phalanges and composite phalange length but not in the distal phalanx. CONCLUSION In Afro-Caribbean children, mean radiographic 2D:4D was lower than that of White children and sexual dimorphism of 2D:4D (boys<girls) was confined to the distal phalanx and fingertip soft-tissue. In contrast in White children, there were no sex differences in the distal phalanx but there were in the middle-, proximal and composite phalanges (boys<girls). We discuss whether these differences in 2D:4D are widespread among Blacks and Whites and the implications for the interpretation of radiographic 2D:4D and morphological soft-tissue 2D:4D across macro-ethnic groups.
Collapse
Affiliation(s)
- R Trivers
- Biosocial Research Foundation, Southfield, St Elizabeth, Jamaica
| | - A Jacobson
- Department of Anthropology, Rutgers University, New Brunswick, NJ, USA
| | - J T Manning
- Applied Sports, Technology, Exercise, and Medicine (A-STEM), Swansea University, Swansea, United Kingdom.
| |
Collapse
|
11
|
Yan S, Mojica J, Barbee D, Harrison L, Gamez M, Tam M, Concert C, Li Z, Culliney B, Jacobson A, Persky M, DeLacure M, Persky M, Tran T, Givi B, Hu K. De-escalation with Definitive Unilateral Neck Radiation for T3 or N2b/N3 p16+ Tonsil Squamous Cell Carcinoma Using Prospectively Defined Criteria. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2019.11.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
12
|
Yan S, Mojica J, Barbee D, Harrison L, Gamez M, Tam M, Concert C, Li Z, Culliney B, Jacobson A, Persky M, DeLacure M, Persky M, Tran T, Givi B, Hu K. De-escalation in HPV Era: Definitive Unilateral Neck Radiation for T3 or N2b/N3 p16+ Tonsil Squamous Cell Carcinoma Using Prospectively Defined Criteria. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Slonim T, Jacobson A, Haase-Alasantro L, Marvin M, Frank C, Murphy C. A-19 Inhibition in Metabolic Syndrome and its Relationship to Orbitofrontal Cortex Activation During Sucrose Evaluation. Arch Clin Neuropsychol 2019. [DOI: 10.1093/arclin/acz034.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Objective
Metabolic syndrome(MetS) is associated with disinhibited eating,executive dysfunction,and increased risk of dementia. The orbitofrontal cortex(OFC) has been implicated in literature as an area involved with decision making and reward. Decreased OFC volume has been linked to disinhibited eating and poorer executive functioning skills.However,research examining executive functioning in individuals with MetS fails to address the role of inhibition as it pertains to consumption and risk of developing MetS. We examined the relationship between neuropsychological performance and OFC activation after receiving and rating a sucrose stimulus to determine if OFC activation is associated with executive functioning deficits that may lead to developing MetS.
Method
Participants were categorized by MetS status(n = 46) and Control(n = 34) with mean age of 49.13±20.29years. During an fMRI session, the Blood-Oxygenation-Level-Dependent(BOLD) response of OFC was recorded while participants rated the pleasantness of an aqueous sucrose solution. Participants were administered the Color-Word Interference Test outside the scanner. Partial Correlation analyses controlling for age examined the relationship between OFC activation during hedonic ratings of sucrose and cognitive performance.
Results
There was a significant negative relationship between left OFC activity and Color-Word Interference:Inhibition performance for Controls(r(42) = -.365, p = .015) as compared to MetS(r(30) = .141,p > .05).
Conclusions
Less activity in the OFC during sucrose hedonic rating was associated with better performance on the Inhibition condition for Controls. We speculate that decreased activation in the OFC after sucrose consumption reflects intact executive functioning and perhaps even a preventative factor to developing MetS. Alternatively, it could indicate that Controls are actively inhibiting hedonic responses to sucrose which improves their ability on a test of inhibition.
Collapse
|
14
|
Nakajima K, Nakata T, Matsuo S, Doi T, Jacobson A. 239Machine learning model for predicting sudden cardiac death and heart failure death using 123I-metaiodobenzylguanidine. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez145.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- K Nakajima
- Kanazawa University Hospital, Kanazawa, Japan
| | - T Nakata
- Hakodate Goryoukaku Hospital, Hakodate, Japan
| | - S Matsuo
- Kanazawa University Hospital, Kanazawa, Japan
| | - T Doi
- Teine Keijinkai Hospital, Sapporo, Japan
| | - A Jacobson
- Diagram Consulting, Kihei, United States of America
| |
Collapse
|
15
|
Wang H, Miao R, Jacobson A, Boyd G, Goldberg S, Cote G, Choy E, Hornicek F, Raskin K, DeLaney T, Chen Y. Nodal Involvement and Survival Analysis in Synovial, Clear Cell, Angio, Rhabdo, and Epithelioid(SCARE) Sarcoma. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.06.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
16
|
Chen Y, Miao R, Goldberg S, Jacobson A, Wang H, Cote G, Choy E, Hornicek F, DeLaney T. Significant Risk of Secondary Malignancy In Ewing Sarcoma and Osteosarcoma Survivors. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.1989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
17
|
Jacobson A, Dreyer CJ. The treatment of the cleft lip and palate patient. SAJCD 2018. [DOI: 10.4102/sajcd.v6i1.484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
No abstract available.
Collapse
|
18
|
Tang WW, McGee P, Lachin JM, Li DY, Hoogwerf B, Hazen SL, Nathan D, Zinman B, Crofford O, Genuth S, Brown‐Friday J, Crandall J, Engel H, Engel S, Martinez H, Phillips M, Reid M, Shamoon H, Sheindlin J, Gubitosi‐Klug R, Mayer L, Pendegast S, Zegarra H, Miller D, Singerman L, Smith‐Brewer S, Novak M, Quin J, Genuth S, Palmert M, Brown E, McConnell J, Pugsley P, Crawford P, Dahms W, Gregory N, Lackaye M, Kiss S, Chan R, Orlin A, Rubin M, Brillon D, Reppucci V, Lee T, Heinemann M, Chang S, Levy B, Jovanovic L, Richardson M, Bosco B, Dwoskin A, Hanna R, Barron S, Campbell R, Bhan A, Kruger D, Jones J, Edwards P, Bhan A, Carey J, Angus E, Thomas A, Galprin A, McLellan M, Whitehouse F, Bergenstal R, Johnson M, Gunyou K, Thomas L, Laechelt J, Hollander P, Spencer M, Kendall D, Cuddihy R, Callahan P, List S, Gott J, Rude N, Olson B, Franz M, Castle G, Birk R, Nelson J, Freking D, Gill L, Mestrezat W, Etzwiler D, Morgan K, Aiello L, Golden E, Arrigg P, Asuquo V, Beaser R, Bestourous L, Cavallerano J, Cavicchi R, Ganda O, Hamdy O, Kirby R, Murtha T, Schlossman D, Shah S, Sharuk G, Silva P, Silver P, Stockman M, Sun J, Weimann E, Wolpert H, Aiello L, Jacobson A, Rand L, Rosenzwieg J, Nathan D, Larkin M, Christofi M, Folino K, Godine J, Lou P, Stevens C, Anderson E, Bode H, Brink S, Cornish C, Cros D, Delahanty L, eManbey ., Haggan C, Lynch J, McKitrick C, Norman D, Moore D, Ong M, Taylor C, Zimbler D, Crowell S, Fritz S, Hansen K, Gauthier‐Kelly C, Service F, Ziegler G, Barkmeier A, Schmidt L, French B, Woodwick R, Rizza R, Schwenk W, Haymond M, Pach J, Mortenson J, Zimmerman B, Lucas A, Colligan R, Luttrell L, Lopes‐Virella M, Caulder S, Pittman C, Patel N, Lee K, Nutaitis M, Fernandes J, Hermayer K, Kwon S, Blevins A, Parker J, Colwell J, Lee D, Soule J, Lindsey P, Bracey M, Farr A, Elsing S, Thompson T, Selby J, Lyons T, Yacoub‐Wasef S, Szpiech M, Wood D, Mayfield R, Molitch M, Adelman D, Colson S, Jampol L, Lyon A, Gill M, Strugula Z, Kaminski L, Mirza R, Simjanoski E, Ryan D, Johnson C, Wallia A, Ajroud‐Driss S, Astelford P, Leloudes N, Degillio A, Schaefer B, Mudaliar S, Lorenzi G, Goldbaum M, Jones K, Prince M, Swenson M, Grant I, Reed R, Lyon R, Kolterman O, Giotta M, Clark T, Friedenberg G, Sivitz W, Vittetoe B, Kramer J, Bayless M, Zeitler R, Schrott H, Olson N, Snetselaar L, Hoffman R, MacIndoe J, Weingeist T, Fountain C, Miller R, Johnsonbaugh S, Patronas M, Carney M, Mendley S, Salemi P, Liss R, Hebdon M, Counts D, Donner T, Gordon J, Hemady R, Kowarski A, Ostrowski D, Steidl S, Jones B, Herman W, Martin C, Pop‐Busui R, Greene D, Stevens M, Burkhart N, Sandford T, Floyd J, Bantle J, Flaherty N, Terry J, Koozekanani D, Montezuma S, Wimmergren N, Rogness B, Mech M, Strand T, Olson J, McKenzie L, Kwong C, Goetz F, Warhol R, Hainsworth D, Goldstein D, Hitt S, Giangiacomo J, Schade D, Canady J, Burge M, Das A, Avery R, Ketai L, Chapin J, Schluter M, Rich J, Johannes C, Hornbeck D, Schutta M, Bourne P, Brucker A, Braunstein S, Schwartz S, Maschak‐Carey B, Baker L, Orchard T, Cimino L, Songer T, Doft B, Olson S, Becker D, Rubinstein D, Bergren R, Fruit J, Hyre R, Palmer C, Silvers N, Lobes L, Rath PP, Conrad P, Yalamanchi S, Wesche J, Bratkowksi M, Arslanian S, Rinkoff J, Warnicki J, Curtin D, Steinberg D, Vagstad G, Harris R, Steranchak L, Arch J, Kelly K, Ostrosaka P, Guiliani M, Good M, Williams T, Olsen K, Campbell A, Shipe C, Conwit R, Finegold D, Zaucha M, Drash A, Morrison A, Malone J, Bernal M, Pavan P, Grove N, Tanaka E, McMillan D, Vaccaro‐Kish J, Babbione L, Solc H, DeClue T, Dagogo‐Jack S, Wigley C, Ricks H, Kitabchi A, Chaum E, Murphy M, Moser S, Meyer D, Iannacone A, Yoser S, Bryer‐Ash M, Schussler S, Lambeth H, Raskin P, Strowig S, Basco M, Cercone S, Zinman B, Barnie A, Devenyi R, Mandelcorn M, Brent M, Rogers S, Gordon A, Bakshi N, Perkins B, Tuason L, Perdikaris F, Ehrlich R, Daneman D, Perlman K, Ferguson S, Palmer J, Fahlstrom R, de Boer I, Kinyoun J, Van Ottingham L, Catton S, Ginsberg J, McDonald C, Harth J, Driscoll M, Sheidow T, Mahon J, Canny C, Nicolle D, Colby P, Dupre J, Hramiak I, Rodger N, Jenner M, Smith T, Brown W, May M, Lipps Hagan J, Agarwal A, Adkins T, Lorenz R, Feman S, Survant L, White N, Levandoski L, Grand G, Thomas M, Joseph D, Blinder K, Shah G, Burgess D, Boniuk I, Santiago J, Tamborlane W, Gatcomb P, Stoessel K, Ramos P, Fong K, Ossorio P, Ahern J, Gubitosi‐Klug R, Meadema‐Mayer L, Beck C, Farrell K, Genuth S, Quin J, Gaston P, Palmert M, Trail R, Dahms W, Lachin J, Backlund J, Bebu I, Braffett B, Diminick L, Gao X, Hsu W, Klumpp K, Pan H, Trapani V, Cleary P, McGee P, Sun W, Villavicencio S, Anderson K, Dews L, Younes N, Rutledge B, Chan K, Rosenberg D, Petty B, Determan A, Kenny D, Williams C, Cowie C, Siebert C, Steffes M, Arends V, Bucksa J, Nowicki M, Chavers B, O'Leary D, Polak J, Harrington A, Funk L, Crow R, Gloeb B, Thomas S, O'Donnell C, Soliman E, Zhang Z, Li Y, Campbell C, Keasler L, Hensley S, Hu J, Barr M, Taylor T, Prineas R, Feldman E, Albers J, Low P, Sommer C, Nickander K, Speigelberg T, Pfiefer M, Schumer M, Moran M, Farquhar J, Ryan C, Sandstrom D, Williams T, Geckle M, Cupelli E, Thoma F, Burzuk B, Woodfill T, Danis R, Blodi B, Lawrence D, Wabers H, Gangaputra S, Neill S, Burger M, Dingledine J, Gama V, Sussman R, Davis M, Hubbard L, Budoff M, Darabian S, Rezaeian P, Wong N, Fox M, Oudiz R, Kim L, Detrano R, Cruickshanks K, Dalton D, Bainbridge K, Lima J, Bluemke D, Turkbey E, der Geest ., Liu C, Malayeri A, Jain A, Miao C, Chahal H, Jarboe R, Nathan D, Monnier V, Sell D, Strauch C, Hazen S, Pratt A, Tang W, Brunzell J, Purnell J, Natarajan R, Miao F, Zhang L, Chen Z, Paterson A, Boright A, Bull S, Sun L, Scherer S, Lopes‐Virella M, Lyons T, Jenkins A, Klein R, Virella G, Jaffa A, Carter R, Stoner J, Garvey W, Lackland D, Brabham M, McGee D, Zheng D, Mayfield R, Maynard J, Wessells H, Sarma A, Jacobson A, Dunn R, Holt S, Hotaling J, Kim C, Clemens Q, Brown J, McVary K. Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study. J Am Heart Assoc 2018. [PMCID: PMC6015340 DOI: 10.1161/jaha.117.008368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background
Hyperglycemia leading to increased oxidative stress is implicated in the increased risk for the development of macrovascular and microvascular complications in patients with type 1 diabetes mellitus.
Methods and Results
A random subcohort of 349 participants was selected from the
DCCT
/
EDIC
(Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications) cohort. This included 320 controls and 29 cardiovascular disease cases that were augmented with 98 additional known cases to yield a case cohort of 447 participants (320 controls, 127 cases). Biosamples from
DCCT
baseline, year 1, and closeout of
DCCT
, and 1 to 2 years post‐
DCCT
(
EDIC
years 1 and 2) were measured for markers of oxidative stress, including plasma myeloperoxidase, paraoxonase activity, urinary F
2α
isoprostanes, and its metabolite, 2,3 dinor‐8
iso
prostaglandin F
2α
. Following adjustment for glycated hemoblobin and weighting the observations inversely proportional to the sampling selection probabilities, higher paraoxonase activity, reflective of antioxidant activity, and 2,3 dinor‐8
iso
prostaglandin F
2α
, an oxidative marker, were significantly associated with lower risk of cardiovascular disease (−4.5% risk for 10% higher paraoxonase,
P
<0.003; −5.3% risk for 10% higher 2,3 dinor‐8
iso
prostaglandin F
2α
,
P
=0.0092). In contrast, the oxidative markers myeloperoxidase and F
2α
isoprostanes were not significantly associated with cardiovascular disease after adjustment for glycated hemoblobin. There were no significant differences between
DCCT
intensive and conventional treatment groups in the change in all biomarkers across time segments.
Conclusions
Heightened antioxidant activity (rather than diminished oxidative stress markers) is associated with lower cardiovascular disease risk in type 1 diabetes mellitus, but these biomarkers did not change over time with intensification of glycemic control.
Clinical Trial Registration
URL
:
https://www.clinicaltrials.gov
. Unique identifiers:
NCT
00360815 and
NCT
00360893.
Collapse
Affiliation(s)
- W.H. Wilson Tang
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | - Paula McGee
- The Biostatistics Center, George Washington University, Rockville, MD
| | - John M. Lachin
- The Biostatistics Center, George Washington University, Rockville, MD
| | - Daniel Y. Li
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
| | | | - Stanley L. Hazen
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Tam M, Mojica J, Kim N, No D, Li Z, Tran T, DeLacure M, Givi B, Jacobson A, Persky M, Hu K. Functional Swallowing Outcomes Using FEES Evaluation After Swallowing-Sparing IMRT in Unilateral Versus Bilateral Neck Radiation. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2017.12.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
20
|
Wu S, Tam M, Gerber N, Li Z, Schmidt B, Persky M, Sanfilippo N, Tran T, Jacobson A, DeLacure M, Hu K, Persky M, Schreiber D, Givi B. Utilization of Immunotherapy in Head and Neck Cancers Pre-Food and Drug Administration Approval of Immune Checkpoint Inhibitors. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2017.12.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
21
|
Konieczkowski D, Miao R, Spentzos D, Duan Z, Wang H, Jacobson A, Stanton T, Choy E, Cote G, Hornicek F, DeLaney T, Chen Y. Clinical Characteristics, Patterns of Care, and Treatment Outcomes of Radiation-Associated Osteosarcoma Compared to Spontaneous Osteosarcoma in a Large Single-Institution Series. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
22
|
Miao R, Wang H, Jacobson A, Cote G, Choy E, Raskin K, Hornicek F, Schwab J, DeLaney T, Chen Y. Clinical Characteristics and Treatment Outcomes of Radiation-Associated and Spontaneous Malignant Peripheral Nerve Sheath Tumor. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2418] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Chen Y, Miao R, Raskin K, Hornicek F, Jacobson A, DeLaney T, Haynes A. Optimal Management of Subcutaneous Myxofibrosarcoma: Impact of Initial Surgical Intervention on Oncologic Outcomes. Int J Radiat Oncol Biol Phys 2017. [DOI: 10.1016/j.ijrobp.2017.06.2406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
24
|
Sanford N, Wang H, Goldberg S, Chen Y, Jacobson A, Choy E, Cote G, Stanton T, Hornicek F, DeLaney T, Harmon D. Secondary Leukemia and Myelodysplastic Syndrome in 375 Patients With Ewing Sarcoma and Osteosarcoma. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
25
|
Raldow A, Jacobson A, Goldberg S, Wang H, Choy E, Cote G, Hornicek F, DeLaney T, Chen Y. Adult Rhabdomyosarcoma: A Retrospective Analysis of 40 Patients Treated at a Single Institution. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Wang H, Jacobson A, Goldberg S, Stanton T, Harmon D, Choy E, Cote G, Hornicek F, Raskin K, DeLaney T, Nielsen G, Chen Y. Osteosarcoma of the Spine and Pelvis: One hundred fifteen Patients of a Single Institution. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.2401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
27
|
Hu K, Stewart R, Jacobson A, Persky M, Schantz S, Tran T, Urken M, Culliney B, Li Z, Harrison L. Prognostic Value of Midtreatment Nodal Response to Chemoradiation in Oropharyngeal Squamous Cell Carcinomas: Implications for Treatment Modification. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2015.12.111] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
28
|
Chadha J, Hu K, Jacobson A, Persky M, Schantz S, Tran T, Urken M, Li Z, Culliney B, Harrison L. The Role of Brachytherapy in Treatment of Oral Tongue Cancer. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2015.12.084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
29
|
Mourad W, Hu K, Shasha D, Concert C, Ryniak M, Shourbaji R, Rabatic B, Zaenger D, Khorsandi A, Culliney B, Li Z, Tran T, Jacobson A, Urken M, Schantz S, Persky M, Harrison L. The Impact of HPV, HIV, and Smoking on Patients With Oropharynx Cancer and Metastases of Unknown Primary of the Head and Neck. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1382] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
30
|
Stewart R, Hu K, Li Z, Culliney B, Persky M, Jacobson A, Urken M, Tran T, Schantz S, Harrison L. Use of Cone Beam CT to Assess Midtreatment Nodal Response to Chemoradiation Therapy in Oropharyngeal Squamous Cell Carcinomas: Implications for Adaptive Radiation Therapy. Int J Radiat Oncol Biol Phys 2015. [DOI: 10.1016/j.ijrobp.2015.07.1320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
31
|
Pellegrino T, Petretta M, Boemio A, Piscopo V, Carotenuto R, Russo B, Pellegrino S, De Matteis G, Cuocolo A, Ryzhkova DV, Kostina I, Azevedo Coutinho M, Cortez-Dias N, Cantinho G, Guimaraes T, Silva G, Menezes M, Francisco A, Placido R, Conceicao I, Pinto F, Nakajima K, Nakata T, Matsuo S, Jacobson A, Paterson CA, Al Jabri AJ, Robinson J, Martin W, Reid S, Smith SA, Harms H, Tolbod L, Kero T, Bouchelouche K, Frokiaer J, Sorensen J, Matsuo S, Nakajima K, Kinuya S, Yamagishi M. Moderated Poster Session 3: Monday 4 May 2015, 10:00-11:00 * Room: Moderated Poster Area. Eur Heart J Cardiovasc Imaging 2015. [DOI: 10.1093/ehjci/jev049] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
32
|
Jacobson A, Giraud C, Hornicek F, Raskin K, Schwab J, Mullen J, Harmon D, Choy E, Nielsen G, DeLaney T, Chen Y. Outcomes of Patients With Synovial Sarcomas Treated With Multimodality Therapy: A Single-Institution Review. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
33
|
Bhatt A, Jacobson A, Lee R, Giraud C, Schwab J, Hornicek F, Nielsen P, Choy E, Harmon D, DeLaney T, Chen Y. High-Dose Proton Beam Boosted Radiation Therapy in the Management of Non–Skull Base Chondrosarcomas. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2219] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
34
|
Yip D, DeLaney T, Jacobson A, Hornicek F, Schwab J, Mauceri T, Chen Y. Review of Experience and Outcome of Dural Plaque Brachytherapy:2000-2013. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2200] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
35
|
Huang P, Jacobson A, Giraud C, Choy E, Harmon D, DeLaney T, Chen Y. Outcomes of Head and Neck Osteosarcoma: Ten-Year Experience at a Single Institution. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
36
|
Wang H, Jacobson A, Harmon D, Michaelson J, DeLaney T, Chen Y. Prognostic Factors in Alveolar Soft-Part Sarcoma: A SEER Analysis. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.2193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
37
|
Accacha S, Rosenfeld W, Jacobson A, Michel L, Schnurr FJ, Shelov S, Ten S, Boucher-Berry C, Carey DE, Speiser PW, Lowell B, Conroy R, Klein M, Fennoy I, Rapaport R, Rosenbaum M. Plasma advanced glycation end products (AGEs), receptors for AGEs and their correlation with inflammatory markers in middle school-age children. Horm Res Paediatr 2014; 80:318-27. [PMID: 24217195 DOI: 10.1159/000354831] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/04/2013] [Accepted: 08/02/2013] [Indexed: 11/19/2022] Open
Abstract
AIM Advanced glycation end products (AGEs) and/or their receptors (RAGE) are significantly positively correlated with adiposity, inflammation, dyslipidemia, and insulin resistance in adults. However, the relationships between AGEs, RAGE, and adiposity-related comorbidites in children have not been well studied. METHODS In a cross-sectional study of 88 children (age 11-15 years) from the New York area enrolled in the Reduce Obesity and Diabetes (ROAD) study, we examined the correlation of the AGE N(ε)-(carboxymethyl)lysine (CML), soluble RAGE (sRAGE), and endogenous secretory RAGE (esRAGE) with adiposity, inflammatory markers [interleukin-6 (IL-6), C-reactive protein, tumor necrosis factor-α], adiponectin, lipids, insulin sensitivity, and insulin secretory capacity. RESULTS Pediatric CML levels were ~20% below average adult levels. CML was significantly (p < 0.05) positively correlated with age and insulin sensitivity and negatively with adiposity, dyslipidemia and IL-6. sRAGE correlated positively with esRAGE and negatively with adiposity and IL-6. Both sRAGE and esRAGE correlated negatively with insulin secretory capacity. CONCLUSION Our findings suggest that unlike adults, CML is negatively associated with adiposity and adiposity-related comorbidity risk in children. As in adults, sRAGE and esRAGE were, to varying degrees, negatively correlated with body fatness and risk factors for adiposity-related comorbidities.
Collapse
Affiliation(s)
- S Accacha
- Pediatrics, Winthrop University Hospital, Mineola, N.Y., USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, Jacobson A, Persky M, Tran T, Concert C, Palacios D, Metcalfe-Klaw R, Kumar M, Bennett B, Harrison L. Functional Outcomes and Quality of Life After Chemoradiotherapy: Baseline and 3 and 6 Months Post-Treatment. Dysphagia 2014; 29:365-75. [DOI: 10.1007/s00455-014-9519-8] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2013] [Accepted: 02/07/2014] [Indexed: 10/25/2022]
|
39
|
Jacobson A, Huang P, Choy E, Harmon D, DeLaney T, Chen Y. Effect of Adjuvant Radiation Therapy on Survival in Head and Neck Osteosarcoma. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2013.11.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Dhanireddy B, Hu K, Schwab B, Gamez M, Culliney B, Li Z, Persky M, Urken M, Jacobson A, Harrison L. Laryngeal Preservation in Stage III/IV Larynx Cancer Treated With Conformal Radiation and Chemotherapy. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2013.11.075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Leal AD, Kadakia KC, Looker S, Hilger C, Sorgatz K, Anderson K, Jacobson A, Grendahl D, Seisler D, Hobday T, Loprinzi CL. Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy. Support Care Cancer 2014; 22:1313-7. [PMID: 24402411 DOI: 10.1007/s00520-013-2089-8] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2013] [Accepted: 12/05/2013] [Indexed: 11/28/2022]
Abstract
PURPOSE The purpose of this study was to investigate the incidence of fosaprepitant-associated infusion site adverse events (ISAEs) among a cohort of breast cancer patients receiving doxorubicin/cyclophosphamide (AC) chemotherapy. METHODS A retrospective review of electronic medical record (EMR) data was performed for all patients who were initiated on AC from January 2011 to April 2012. Data collected included baseline demographics, antiemetic regimen, documentation of ISAEs, and type of intravenous (IV) access. Descriptive statistics (mean and standard deviation or percentages) were summarized overall, by type of IV access and initial antiemetic given. RESULTS Among the 148 patients included in this analysis, 98 initially received fosaprepitant and 44 received aprepitant. The incidence of ISAEs associated with fosaprepitant administration was 34.7 % (n=34), while the incidence of aprepitant-associated ISAEs was 2.3 % (n=1). All ISAEs were associated with peripheral IV access. The most commonly reported ISAEs were infusion site pain (n=26), erythema (n=22), swelling (n=12), superficial thrombosis (n=8), infusion site hives (n=5), and phlebitis/thrombophlebitis (n=5). Twenty-six patients experienced more than one type of ISAE. CONCLUSIONS The incidence and severity of ISAEs associated with fosaprepitant administration among a group of patients receiving AC chemotherapy are significant and appreciably higher than what has been previously reported.
Collapse
Affiliation(s)
- A D Leal
- Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Durant SM, Wacher T, Bashir S, Woodroffe R, De Ornellas P, Ransom C, Newby J, Abáigar T, Abdelgadir M, El Alqamy H, Baillie J, Beddiaf M, Belbachir F, Belbachir-Bazi A, Berbash AA, Bemadjim NE, Beudels-Jamar R, Boitani L, Breitenmoser C, Cano M, Chardonnet P, Collen B, Cornforth WA, Cuzin F, Gerngross P, Haddane B, Hadjeloum M, Jacobson A, Jebali A, Lamarque F, Mallon D, Minkowski K, Monfort S, Ndoassal B, Niagate B, Purchase G, Samaïla S, Samna AK, Sillero-Zubiri C, Soultan AE, Stanley Price MR, Pettorelli N. Fiddling in biodiversity hotspots while deserts burn? Collapse of the Sahara's megafauna. DIVERS DISTRIB 2013. [DOI: 10.1111/ddi.12157] [Citation(s) in RCA: 83] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
43
|
Gamez M, Hu K, Wallach J, Husaini H, Mourad W, Kumar M, Culliney B, Jacobson A, Urken M, Harrison L. Excellent Outcomes and Orbital Preservation for Advanced T4 Sino-Nasal Cancers Using Combined Chemotherapy, Intensity Modulated Radiation Therapy, and Surgery. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
44
|
Hu K, Tran T, Wallach J, Lin W, Khorsandi A, Holliday R, Persky M, Urken M, Jacobson A, Harrison L. Prospective Multidisciplinary Treatment Algorithm for Head and Neck Paragangliomas. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
45
|
Husaini H, Lazarus C, Hu K, Urken M, Jacobson A, Kumar M, Metcalfe-Klaw R, Harrison L. EORTC QOL Rating, Performance Status, and Oral Outcomes in Head-and-Neck Cancer Patients Treated With Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 2013. [DOI: 10.1016/j.ijrobp.2013.06.1164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
46
|
Creel S, Becker MS, Durant SM, M'Soka J, Matandiko W, Dickman AJ, Christianson D, Dröge E, Mweetwa T, Pettorelli N, Rosenblatt E, Schuette P, Woodroffe R, Bashir S, Beudels-Jamar RC, Blake S, Borner M, Breitenmoser C, Broekhuis F, Cozzi G, Davenport TRB, Deutsch J, Dollar L, Dolrenry S, Douglas-Hamilton I, Fitzherbert E, Foley C, Hazzah L, Henschel P, Hilborn R, Hopcraft JGC, Ikanda D, Jacobson A, Joubert B, Joubert D, Kelly MS, Lichtenfeld L, Mace GM, Milanzi J, Mitchell N, Msuha M, Muir R, Nyahongo J, Pimm S, Purchase G, Schenck C, Sillero-Zubiri C, Sinclair ARE, Songorwa AN, Stanley-Price M, Tehou CA, Trout C, Wall J, Wittemyer G, Zimmermann A. Conserving large populations of lions - the argument for fences has holes. Ecol Lett 2013; 16:1413, e1-3. [DOI: 10.1111/ele.12145] [Citation(s) in RCA: 61] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2013] [Revised: 06/03/2013] [Accepted: 06/04/2013] [Indexed: 11/27/2022]
Affiliation(s)
- S. Creel
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
| | - M. S. Becker
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - S. M. Durant
- Institute of Zoology; Zoological Society of London; Regents Park London NW1 4RY UK
- Wildlife Conservation Society, Bronx Zoo; 2300 Southern Blvd. Bronx NY 10460 USA
| | - J. M'Soka
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
- Zambia Wildlife Authority; Private Bag 1 Chilanga Zambia
| | - W. Matandiko
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - A. J. Dickman
- Wildlife Conservation Research Unit, Department of Zoology; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
| | - D. Christianson
- School of Natural Resources and the Environment; University of Arizona; Tucson AZ 85721 USA
| | - E. Dröge
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - T. Mweetwa
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - N. Pettorelli
- Institute of Zoology; Zoological Society of London; Regents Park London NW1 4RY UK
| | - E. Rosenblatt
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - P. Schuette
- Department of Ecology; Conservation Biology and Ecology Program; Montana State University; 310 Lewis Hall Bozeman MT 59717 USA
- Zambian Carnivore Programme; Box 80 Mfuwe Eastern Province Zambia
| | - R. Woodroffe
- Institute of Zoology; Zoological Society of London; Regents Park London NW1 4RY UK
| | - S. Bashir
- Institute of Zoology; Zoological Society of London; Regents Park London NW1 4RY UK
| | - R. C. Beudels-Jamar
- Royal Belgian Institute of Natural Sciences; 29 Vautier str. Bruxelles 1000 Belgium
- CMS Scientific Council, UNEP/CMS; Hermann-Ehlers-Str. 10 Bonn 53113 Germany
| | - S. Blake
- Max Planck Institute for Ornithology; Whitney R. Harris World Ecology Center; Washington University in St. Louis; St. Louis 63130 USA
| | - M. Borner
- Institute of Biodiversity, Animal Health and Comparative Medicine; University of Glasgow; University Avenue Glasgow G12 8QQ UK
| | - C. Breitenmoser
- IUCN/SSC Cat Specialist Group; c/o KORA, Thunstrasse 31 Muri 3074 Switzerland
| | - F. Broekhuis
- Wildlife Conservation Research Unit, Department of Zoology; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
| | - G. Cozzi
- Institute of Evolutionary Biology and Environmental Studies; Zurich University; Winterthurerstrasse 190 Zürich CH 8057 Switzerland
| | - T. R. B. Davenport
- Wildlife Conservation Society, Tanzania Program; PO Box 922 Zanzibar Tanzania
| | - J. Deutsch
- Wildlife Conservation Society, Bronx Zoo; 2300 Southern Blvd. Bronx NY 10460 USA
| | - L. Dollar
- Big Cats Initiative, National Geographic Society; 1145 17th Street NW Washington DC 20036-4688 USA
- Nicholas School of the Environment; Duke University; Durham North Carolina USA
- Department of Biology; Pfeiffer University; Misenheimer North Carolina 28109 USA
| | - S. Dolrenry
- Lion Guardians; PO Box 15550 Langata 00509 Kenya
| | - I. Douglas-Hamilton
- Save the Elephants; PO Box 54667 Nairobi Kenya
- Department of Zoology; University of Oxford; Oxford OX1 3PS UK
| | - E. Fitzherbert
- Wildlife Conservation Research Unit, Department of Zoology; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
- Chester Zoo; Chester CH2 1LH UK
| | - C. Foley
- Wildlife Conservation Society, Tanzania Program; PO Box 922 Zanzibar Tanzania
| | - L. Hazzah
- Lion Guardians; PO Box 15550 Langata 00509 Kenya
| | - P. Henschel
- Panthera; 8 West 40th Street, 18th Floor New York NY 10018 USA
| | - R. Hilborn
- School of Aquatic and Fishery Sciences; University of Washington; Seattle WA 98195 USA
| | - J. G. C. Hopcraft
- Institute of Biodiversity, Animal Health and Comparative Medicine; University of Glasgow; University Avenue Glasgow G12 8QQ UK
| | - D. Ikanda
- Tanzania Wildlife Research Institute; Box 661 Arusha Tanzania
| | - A. Jacobson
- Institute of Zoology; Zoological Society of London; Regents Park London NW1 4RY UK
| | - B. Joubert
- Big Cats Initiative, National Geographic Society; 1145 17th Street NW Washington DC 20036-4688 USA
| | - D. Joubert
- Big Cats Initiative, National Geographic Society; 1145 17th Street NW Washington DC 20036-4688 USA
| | - M. S. Kelly
- Department of Fish and Wildlife Conservation; Virginia Tech; 146 Cheatham Hall Blacksburg VA 24061-0321 USA
| | - L. Lichtenfeld
- African People & Wildlife Fund; PO Box 624 Bernardsville NJ 07924 USA
| | - G. M. Mace
- Department of Genetics, Evolution and Environment; Centre for Biodiversity and Environment Research; University College London; Gower Street London WC1E 6BT UK
| | - J. Milanzi
- Zambia Wildlife Authority; Private Bag 1 Chilanga Zambia
| | - N. Mitchell
- Wildlife Conservation Society, Bronx Zoo; 2300 Southern Blvd. Bronx NY 10460 USA
- Conservation Programmes, Zoological Society of London; Regents Park London NW1 4RY UK
| | - M. Msuha
- Tanzania Wildlife Research Institute; Box 661 Arusha Tanzania
| | - R. Muir
- Africa Programme, Frankfurt Zoological Society Africa Regional Office; Serengeti National Park; Serengeti Tanzania
| | | | - S. Pimm
- Nicholas School of the Environment; Duke University; Durham North Carolina USA
- Department of Biology; Pfeiffer University; Misenheimer North Carolina 28109 USA
| | - G. Purchase
- Wildlife Conservation Society, Bronx Zoo; 2300 Southern Blvd. Bronx NY 10460 USA
- Conservation Programmes, Zoological Society of London; Regents Park London NW1 4RY UK
| | - C. Schenck
- Frankfurt Zoological Society; Bernhard-Grzimek-Allee 1 Frankfurt 60316 Germany
| | - C. Sillero-Zubiri
- Department of Zoology; IUCN/SSC Canid Specialist Group Wildlife Conservation Research Unit; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
| | - A. R. E. Sinclair
- Beaty Biodiversity Research Centre; University of British Columbia; 6270 University Boulevard Vancouver V6T 1Z4 Canada
| | | | - M. Stanley-Price
- Wildlife Conservation Research Unit, Department of Zoology; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
- IUCN/SSC Species Conservation Planning Sub-committee; Rue Mauverney 28 1196 Gland Switzerland
| | - C. A. Tehou
- Coordonnateur WAP/UNOPS Bénin; B.P. 527 Cotonou, République Bénin
| | - C. Trout
- African People & Wildlife Fund; PO Box 624 Bernardsville NJ 07924 USA
| | - J. Wall
- Laboratory for Advanced Spatial Analysis; Department of Geography; University of British Columbia; 1984 West Mall Vancouver BC V6T 1Z2 Canada
| | - G. Wittemyer
- Fish, Wildlife and Conservation Biology; Colorado State University; Fort Collins Colorado 80523 USA
| | - A. Zimmermann
- Wildlife Conservation Research Unit, Department of Zoology; The Recanati-Kaplan Centre; University of Oxford; Tubney House Tubney OX13 5QL UK
- Chester Zoo; Chester CH2 1LH UK
| |
Collapse
|
47
|
Mourad W, Hu K, Shourbaji R, Lin W, Kaplan-Marans E, Jacobson A, Tran T, Urken M, Persky M, Harrison L. The Impact of Radiation Therapy (RT) Duration and Dose per Fraction on Long-term Outcomes in the Management of Benign Lymphoepithelial Cysts of Parotid Glands in HIV Seropositive Patients. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
48
|
Hu K, Mourad W, Shourbaji R, Lin W, Culliney B, Jacobson A, Tran T, Urken M, Persky M, Harrison L. Five-year Outcomes of Oropharynx (OPX) Targeted Radiation Therapy (RT) for Metastatic Squamous Cell Carcinoma of Unknown Primary (MUP) in the Head and Neck. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
49
|
Berlach D, Hu K, Husaini H, Lazarus C, Jacobson A, Urken M, Persky M, Tran T, Culliney B, Harrison L. High-dose-rate Intraoperative Radiation Therapy Combined With Neck Dissection to Salvage Isolated Cervical Nodal Recurrences. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.1386] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
50
|
Durant SM, Pettorelli N, Bashir S, Woodroffe R, Wacher T, De Ornellas P, Ransom C, Abaigar T, Abdelgadir M, El Alqamy H, Beddiaf M, Belbachir F, Belbachir-Bazi A, Berbash AA, Beudels-Jamar R, Boitani L, Breitenmoser C, Cano M, Chardonnet P, Collen B, Cornforth WA, Cuzin F, Gerngross P, Haddane B, Hadjeloum M, Jacobson A, Jebali A, Lamarque F, Mallon D, Minkowski K, Monfort S, Ndoassal B, Newby J, Ngakoutou BE, Niagate B, Purchase G, Samaila S, Samna AK, Sillero-Zubiri C, Soultan AE, Stanley Price MR, Baillie JEM. Forgotten Biodiversity in Desert Ecosystems. Science 2012; 336:1379-80. [DOI: 10.1126/science.336.6087.1379] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|